Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer
BOSTON and OKLAHOMA CITY, June 6, 2023 /PRNewswire/ -- Wheeler Bio, Inc., an agile, boutique, clinical contract development and manufacturing organization (CDMO) today announced the appointment of Dr. Stewart McNaull as Chief Business Officer (CBO). Stewart will be leading the commercialization of Wheeler's proven tech platform – Portable CMC™ – to rapidly advance biologics programs from discovery to clinical leads.
- Dr. Stewart McNaull will help drive Wheeler Bio's mission to rapidly advance biologics programs through its innovative Portable CMC™ technology.
- BOSTON and OKLAHOMA CITY, June 6, 2023 /PRNewswire/ -- Wheeler Bio, Inc., an agile, boutique, clinical contract development and manufacturing organization (CDMO) today announced the appointment of Dr. Stewart McNaull as Chief Business Officer (CBO).
- "I couldn't be more excited to help Wheeler launch their foundational tech stack that will speed our partners' journey from discovery to human proof-of-concept," said Dr. Stewart McNaull, SVP and CBO at Wheeler Bio.
- "I am thrilled to be welcoming Stewart to the team this week at BIO," said Jesse McCool, Co-Founder and CEO at Wheeler Bio.